US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Emera Inc.

46.25

+0.59001.29%

Post-market: 46.250.00000.00%17:05 EDT

Volume:147.35K

Turnover:6.79M

Market Cap:13.78B

PE:22.35

High:46.25

Open:45.75

Low:45.75

Close:45.66

Loading ...

Overview Company News Filings

Is Novo Nordisk Increasing Dosage to Defend Wegovy's Edge in Obesity?

Press Release: Emera Incorporated Announces Conversion Privilege of Cumulative Rate Reset First Preferred Shares, Series A and Cumulative Floating Rate First Preferred Shares, Series B

Four new option listings and three option delistings on July 9th

Moleculin Expands Phase 3 MIRACLE Clinical Trial into the Country of Georgia, Enrollment Update and Future Plans

TIA Tops Market Gains — Can Bulls Reclaim $2 After Strong Weekly Start?

XRP Stuck Below $2.30: Why Is It Not Moving?

Nurix announces EMA grant of Orphan Drug Designation for bexobrutideg

European Medicines Agency Grants Bexobrutideg (NX-5948) Orphan Drug Designation for the Treatment of Lymphoplasmacytic Lymphoma, also Known as Waldenström Macroglobulinemia

Shiba Inu Burn Rate Skyrockets 10,786%: Big Price Movement Ahead?

Hedera’s 5% Rally on Shaky Ground as Sell-Side Pressure Soars

Top 3 Altcoins Gaining Momentum in Nigeria This July

Record 122°C subsurface temperature found in Sembawang, suggesting geothermal energy potential

BONK Rises 22% as ETF Excitement Sparks Fresh Rally

Merck KGaA, Darmstadt, Germany Completes Acquisition of SpringWorks Therapeutics to Accelerate Sustainable Growth of its Healthcare Business

Press Release: Apellis to Receive up to $300 Million from Royalty Purchase Agreement with Sobi for Ex-U.S. Royalties of Aspaveli(R) (systemic pegcetacoplan)

Legend Biotech’s CAR T Cell Therapies See FDA REMS Removal and EMA Label Update

Bitget Onchain Trading Feature Upgrade, Comprehensive Optimization of Take Profit and Stop Loss Module

Lower household electricity and gas tariffs from July to September

SEI Price Is Close to Ending a 5-Month Death Cross After 50% Rally

Aptos Hits 16-Day High as First-Ever Aptos Spot ETF Inches Closer to Reality

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EMA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EMA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EMA\",,,,,undefined,":{"symbol":"EMA","market":"US","secType":"STK","nameCN":"Emera Inc.","latestPrice":46.25,"timestamp":1753128000000,"preClose":45.66,"halted":0,"volume":147347,"hourTrading":{"tag":"盘后","latestPrice":46.25,"preClose":46.25,"latestTime":"17:05 EDT","volume":90868,"amount":4190948.610711,"timestamp":1753131936864},"delay":0,"floatShares":297632664,"shares":297900000,"eps":2.069006,"marketStatus":"Closed","change":0.59,"latestTime":"07-21 16:00:00 EDT","open":45.75,"high":46.25,"low":45.75,"amount":6793916.1437719995,"amplitude":0.010951,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.069006,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1753171200000},"marketStatusCode":5,"adr":0,"exchange":"NYSE","adjPreClose":45.66,"dividendRate":0.045824,"postHourTrading":{"tag":"盘后","latestPrice":46.25,"preClose":46.25,"latestTime":"17:05 EDT","volume":90868,"amount":4190948.610711,"timestamp":1753131936864},"volumeRatio":1.701879,"impliedVol":0,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EMA\",,,,,undefined,":{"symbol":"EMA","floatShares":297632664,"roa":"2.73%","roe":"7.21%","lyrEps":1.186627,"volumeRatio":1.701879,"shares":297900000,"dividePrice":2.107487,"high":46.25,"amplitude":0.010951,"preClose":45.66,"low":45.75,"week52Low":43.9012,"pbRate":"1.53","psRate":"2.40","week52High":46.45,"institutionHeld":0,"latestPrice":46.25,"eps":2.069006,"divideRate":0.045567,"volume":147347,"delay":0,"ttmEps":2.069006,"open":45.75,"prevYearClose":45.28,"prevWeekClose":45.66,"prevMonthClose":45.82,"prevQuarterClose":45.82,"fiveDayClose":45.7,"twentyDayClose":44.16,"earningDate":1754582400000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EMA\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2550442625","title":"Is Novo Nordisk Increasing Dosage to Defend Wegovy's Edge in Obesity?","url":"https://stock-news.laohu8.com/highlight/detail?id=2550442625","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550442625?lang=en_us&edition=fundamental","pubTime":"2025-07-09 23:48","pubTimestamp":1752076080,"startTime":"0","endTime":"0","summary":"Novo NordiskNVO announced that it has submitted a regulatory application to the European Medicines Agency  seeking approval for a new and higher dose of its popular obesity medication, Wegovy. Wegovy is also indicated for major adverse cardiovascular events risk reduction, improvements in HFpEF-related symptoms and physical function, as well as pain reduction related to knee osteoarthritis.Novo Nordisk also markets semaglutide as Ozempic injection and Rybelsus oral tablet for type II diabetes . The EMA submission is backed by data from the STEP UP and STEP UP T2D studies, which evaluated semaglutide 7.2 mg in obese adult patients, with and without T2D. In the STEP UP study, the higher dose of Wegovy led to an average weight loss of 21%, with one-third of participants shedding at least 25% of their body weight compared with placebo. The 7.2 mg dose was well-tolerated and demonstrated a favorable safety profile, aligning with that of the 2.4 mg dose and previous semaglutide studies.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novo-nordisk-increasing-dosage-defend-154800545.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0689472784.USD","LU2361044865.SGD","LU2471134796.USD","LU0882574055.USD","LU1868837136.USD","VKTX","SGXZ57979304.SGD","LU0320765059.SGD","LU2552382215.SGD","BK4534","IE00BKVL7J92.USD","NVO","BK4532","SG9999018865.SGD","SG9999013999.USD","BK4588","LU1917777945.USD","LU2602419157.SGD","SG9999014898.SGD","SG9999001176.SGD","BK4599","EMA","LU1069344957.HKD","LU0256863902.USD","LU0889565916.HKD","LU2552382132.HKD","SG9999015986.USD","LU0094547139.USD","LU1868836591.USD","LU2237443622.USD","LU2456880835.USD","SG9999015978.USD","SG9999018857.SGD","LU1989771016.USD","LU2236285917.USD","LU1548497426.USD","LU0456855351.SGD","LU1127390331.HKD","LU1064131342.USD","LU0385154629.USD","LU1623119135.USD","IE00BJLML261.HKD","LU2237443978.SGD","SG9999014914.USD","LU2237443465.HKD","LU0203202063.USD","IE00B1BXHZ80.USD","LU0238689110.USD","LU2023250504.SGD"],"gpt_icon":1},{"id":"2550659872","title":"Press Release: Emera Incorporated Announces Conversion Privilege of Cumulative Rate Reset First Preferred Shares, Series A and Cumulative Floating Rate First Preferred Shares, Series B","url":"https://stock-news.laohu8.com/highlight/detail?id=2550659872","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550659872?lang=en_us&edition=fundamental","pubTime":"2025-07-09 23:00","pubTimestamp":1752073200,"startTime":"0","endTime":"0","summary":"Emera Incorporated   announced today that it does not intend to exercise its right to redeem all or any part of the currently outstanding Cumulative Rate Reset First Preferred Shares, Series A  or the Cumulative Floating Rate First Preferred Shares, Series B  of the Company on August 15, 2025. There are currently 4,866,814 Series A Shares and 1,133,186 Series B Shares outstanding.As a result, subject to certain conditions set out in the prospectus supplement of the Company dated May 26, 2010, to the short form base shelf prospectus of the Company dated May 19, 2010, relating to the issuance of the Series A Shares and Series B Shares , on August 15, 2025 :.  the holders of Series A Shares have the right, at their option:. to retain any or all of their Series A Shares and continue to receive a. to convert any or all of their Series A Shares, on a one-for-one basis,In either case, Emera will give written notice to that effect","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EMA","BK4081"],"gpt_icon":0},{"id":"2550637024","title":"Four new option listings and three option delistings on July 9th","url":"https://stock-news.laohu8.com/highlight/detail?id=2550637024","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550637024?lang=en_us&edition=fundamental","pubTime":"2025-07-09 20:36","pubTimestamp":1752064594,"startTime":"0","endTime":"0","summary":"New option listings for July 9th include DTCBD Stock (DTCBD), Everus Construction Group Inc (ECG), Emera Incorporated (EMA), and Unity Biotechnolog...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/four-new-option-listings-and-three-option-delistings-on-july-9th-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/four-new-option-listings-and-three-option-delistings-on-july-9th-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EMA","BK4129","ECG","BK4081"],"gpt_icon":0},{"id":"2550637201","title":"Moleculin Expands Phase 3 MIRACLE Clinical Trial into the Country of Georgia, Enrollment Update and Future Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2550637201","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550637201?lang=en_us&edition=fundamental","pubTime":"2025-07-09 20:35","pubTimestamp":1752064500,"startTime":"0","endTime":"0","summary":"Secured approval from the Regulation Agency for Medical and Pharmaceutical Activities (RAMPA) in Georgia for Phase 2B/3 MIRACLE trial Recent EU approval from the European Medicines Agency (EMA) boosts","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/09/3112575/0/en/Moleculin-Expands-Phase-3-MIRACLE-Clinical-Trial-into-the-Country-of-Georgia-Enrollment-Update-and-Future-Plans.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EMA","BK4156","CTA","BK4081"],"gpt_icon":0},{"id":"2549554586","title":"TIA Tops Market Gains — Can Bulls Reclaim $2 After Strong Weekly Start?","url":"https://stock-news.laohu8.com/highlight/detail?id=2549554586","media":"BE[IN]CRYPTO","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549554586?lang=en_us&edition=fundamental","pubTime":"2025-07-08 01:30","pubTimestamp":1751909400,"startTime":"0","endTime":"0","summary":"Celestia’s native TIA coin is up 12%, trading at $1.65 due to growing spot demand and bullish technical indicators.The Elder-Ray Index signals strong buying pressure, reaching its highest value since May 14, suggesting further upward momentum.TIA’s Parabolic SAR indicator shows dynamic support at $1.42, reinforcing bullish sentiment and potential for a rally to $2.As the broader crypto market starts the new trading week on a positive note, Celestia’s native coin, TIA, is today’s top gainer. The altcoin trades at $1.65, up 12% over the past day.Technical indicators point to strong demand from spot traders, hinting at the possibility of an extended rally in the short term. This analysis explains why.Further, readings from TIA’s Parabolic Stop and Reverse indicator show that it has now formed dynamic support below the coin’s current price level. While TIA trades at $1.64, the indicator forms a support floor for its price at $1.42, indicating sustained interest from buyers.","market":"nz","thumbnail":"https://beincrypto.com/wp-content/uploads/2023/12/bic_Celestia_TIA-covers_bullish-850x478.jpg.optimal.jpg","type":0,"news_type":0,"thumbnails":["https://beincrypto.com/wp-content/uploads/2023/12/bic_Celestia_TIA-covers_bullish-850x478.jpg.optimal.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://beincrypto.com/tia-price-rallies-on-spot-demand/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"beincrypto_highlight","symbols":["SAR","BK4135","BK4081","EMA"],"gpt_icon":0},{"id":"2549810553","title":"XRP Stuck Below $2.30: Why Is It Not Moving?","url":"https://stock-news.laohu8.com/highlight/detail?id=2549810553","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549810553?lang=en_us&edition=fundamental","pubTime":"2025-07-07 21:57","pubTimestamp":1751896631,"startTime":"0","endTime":"0","summary":"XRP (CRYPTO: XRP) continues to trade below $2.30 but several positive catalysts could propel the popular cryptocurrency to new highs soon.","market":"nz","thumbnail":"https://www.benzinga.com/files/images/story/2025/07/07/XRP-Ripple.jpeg","type":0,"news_type":0,"thumbnails":["https://www.benzinga.com/files/images/story/2025/07/07/XRP-Ripple.jpeg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/crypto/cryptocurrency/25/07/46274956/xrp-stuck-below-2-30-why-is-it-not-moving","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"Benzinga","symbols":["EMA","BK4081"],"gpt_icon":0},{"id":"2549392805","title":"Nurix announces EMA grant of Orphan Drug Designation for bexobrutideg","url":"https://stock-news.laohu8.com/highlight/detail?id=2549392805","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549392805?lang=en_us&edition=fundamental","pubTime":"2025-07-07 19:05","pubTimestamp":1751886331,"startTime":"0","endTime":"0","summary":"Nurix Therapeutics (NRIX) announced that the European Medicines Agency has granted Orphan Drug Designation to bexobrutideg for the treatment of lym...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nurix-announces-ema-grant-of-orphan-drug-designation-for-bexobrutideg-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nurix-announces-ema-grant-of-orphan-drug-designation-for-bexobrutideg-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4081","NRIX","EMA"],"gpt_icon":0},{"id":"2549539298","title":"European Medicines Agency Grants Bexobrutideg (NX-5948) Orphan Drug Designation for the Treatment of Lymphoplasmacytic Lymphoma, also Known as Waldenström Macroglobulinemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2549539298","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549539298?lang=en_us&edition=fundamental","pubTime":"2025-07-07 19:00","pubTimestamp":1751886000,"startTime":"0","endTime":"0","summary":"Regulatory momentum builds for bexobrutideg with multiple designations across the United States and EU, Including EMA PRIME and FDA Fast Track for CLL/SLLSAN FRANCISCO, July  07, 2025  (GLOBE NEWSWIRE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/07/07/3110913/0/en/European-Medicines-Agency-Grants-Bexobrutideg-NX-5948-Orphan-Drug-Designation-for-the-Treatment-of-Lymphoplasmacytic-Lymphoma-also-Known-as-Waldenstr%C3%B6m-Macroglobulinemia.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1712237335.SGD","BK4534","LU2229751404.USD","NX","LU0347712357.USD","LU1989772923.USD","LU0175139822.USD","IE0009354923.USD","EMA","BK4533","LU2041044095.USD","LU1892829315.USD","LU2092937221.SGD","LU0289961442.SGD","LU0511384066.AUD","LU1430594728.SGD","LU1917777945.USD","LU0289960550.SGD","LU2125910336.SGD","LU2023250504.SGD","LU0472753341.HKD","LU2089279066.USD","LU0124676726.USD","LU1721428933.USD","BK4120","LU2211814178.USD","BK4183","LU2463526074.USD","LU1623119135.USD","MDCO","LU2362541273.HKD","BK4081","LU2023250843.SGD","WM","BK4086","BK4585","LU2298064838.USD","LU2065732104.USD","LU2106854487.HKD","LU2238339852.HKD","ODD","LU2240825500.USD","LU2413666426.HKD","LU2413666699.HKD","LU1939255532.USD","LU1585245621.USD","BK4566","LU0057025933.USD","LU1974910355.USD","LU0689626769.HKD"],"gpt_icon":0},{"id":"2549624534","title":"Shiba Inu Burn Rate Skyrockets 10,786%: Big Price Movement Ahead?","url":"https://stock-news.laohu8.com/highlight/detail?id=2549624534","media":"utoday","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549624534?lang=en_us&edition=fundamental","pubTime":"2025-07-06 12:08","pubTimestamp":1751774880,"startTime":"0","endTime":"0","summary":"The Shiba Inu burn rate surged an astonishing 10,786%, with over 9.5 million SHIB tokens permanently removed from circulation, according todata from Shibburn.Source: Shibburn.comThe SHIB burn mechanis","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://u.today/shiba-inu-burn-rate-skyrockets-10786-big-price-movement-ahead","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"utodaynews_highlight","symbols":["BK4150","EMA","RSI","BK4081"],"gpt_icon":0},{"id":"2549420003","title":"Hedera’s 5% Rally on Shaky Ground as Sell-Side Pressure Soars","url":"https://stock-news.laohu8.com/highlight/detail?id=2549420003","media":"BE[IN]CRYPTO","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549420003?lang=en_us&edition=fundamental","pubTime":"2025-07-06 02:00","pubTimestamp":1751738400,"startTime":"0","endTime":"0","summary":"HBAR has gained 5% in the past week due to increased investor demand and altcoin activity.Technical indicators suggest weakening momentum, with HBAR potentially breaking below its 20-day EMA.If bearish pressure increases, HBAR may retrace to $0.141 or lower; a resurgence in buying could push it past $0.162.Hedera’s native token HBAR has climbed 5% over the past week, driven by increased investor demand and a broader uptick in altcoin activity.However, despite the short-term rally, technical indicators now suggest the momentum is losing steam, signaling a potential pullback in the days ahead.HBAR’s Short-Term Rally Threatened by Weakening Bullish Pressure. An assessment of the HBAR/USD one-day chart shows the altcoin currently testing a break below its 20-day Exponential Moving Average . HBAR currently exchanges hands at $0.155, trading above this key moving average, forming dynamic support at $0.153.Conversely, a resurgence in new demand for HBAR could invalidate this bearish outlook. ","market":"nz","thumbnail":"https://beincrypto.com/wp-content/uploads/2024/04/bic_Hedera_HBAR_5-covers_bearish-850x478.jpg.optimal.jpg","type":0,"news_type":0,"thumbnails":["https://beincrypto.com/wp-content/uploads/2024/04/bic_Hedera_HBAR_5-covers_bearish-850x478.jpg.optimal.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://beincrypto.com/hbars-price-rally-on-shaky-ground-as-sell-side-pressure-soars/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"beincrypto_highlight","symbols":["BK4081","EMA"],"gpt_icon":0},{"id":"2548239670","title":"Top 3 Altcoins Gaining Momentum in Nigeria This July","url":"https://stock-news.laohu8.com/highlight/detail?id=2548239670","media":"BE[IN]CRYPTO","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548239670?lang=en_us&edition=fundamental","pubTime":"2025-07-04 20:00","pubTimestamp":1751630400,"startTime":"0","endTime":"0","summary":"XRP surges in Nigeria due to regulatory clarity and renewed investor interest, with a potential price rally to $2.33.Tron  benefits from USDT’s dominance in Nigeria, seeing a rise in trading volumes and potential to hit $0.296.Crypto markets in Nigeria are starting July on a bullish note, with trading activity picking up across multiple altcoins.This trend reflects a growing appetite among Nigerian investors for emerging opportunities as the broader markets navigate the aftermath of the geopolitical tensions between Iran, Israel, and the US.Alabi told BeInCrypto that Ripple’s XRP has been among the top five traded assets in Luno Nigeria in the last two weeks. This reflects renewed investor interest in the token following several key developments.Alabi noted that sentiment around XRP has been shaped largely by regulatory developments. After years of legal uncertainty in the US, Ripple, XRP’s issuer, recently dropped its cross-appeal against the regulator, ending the protracted legal bat","market":"nz","thumbnail":"https://beincrypto.com/wp-content/uploads/2025/06/altcoin-season-2025-delayed-850x478.png.webp","type":0,"news_type":0,"thumbnails":["https://beincrypto.com/wp-content/uploads/2025/06/altcoin-season-2025-delayed-850x478.png.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://beincrypto.com/altcoins-to-watch-nigeria-july/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"beincrypto_highlight","symbols":["EMA","BK4017","USDT.USD.CC","TRX","TAO","BK4081"],"gpt_icon":0},{"id":"2548822233","title":"Record 122°C subsurface temperature found in Sembawang, suggesting geothermal energy potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2548822233","media":"CNA","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548822233?lang=en_us&edition=fundamental","pubTime":"2025-07-03 20:42","pubTimestamp":1751546520,"startTime":"0","endTime":"0","summary":"Geothermal energy, a clean and renewable source of energy from the ground, could reduce Singapore’s reliance on fossil fuels.","market":"sg","thumbnail":"https://dam.mediacorp.sg/image/upload/s--sqz3d0EW--/c_fill,g_auto,h_468,w_830/f_auto,q_auto/v1/mediacorp/cna/image/2025/07/03/whatsapp_image_2025-07-03_at_4.05.58_pm.jpeg?itok=4dJkIAe_","type":0,"news_type":0,"thumbnails":["https://dam.mediacorp.sg/image/upload/s--sqz3d0EW--/c_fill,g_auto,h_468,w_830/f_auto,q_auto/v1/mediacorp/cna/image/2025/07/03/whatsapp_image_2025-07-03_at_4.05.58_pm.jpeg?itok=4dJkIAe_"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.channelnewsasia.com/singapore/geothermal-energy-potential-sembawang-admiralty-ntu-5218621","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"can_highlight","symbols":["BK4081","EMA"],"gpt_icon":0},{"id":"2548783748","title":"BONK Rises 22% as ETF Excitement Sparks Fresh Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2548783748","media":"BE[IN]CRYPTO","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548783748?lang=en_us&edition=fundamental","pubTime":"2025-07-03 15:00","pubTimestamp":1751526000,"startTime":"0","endTime":"0","summary":"BONK surges 22% as crypto markets rebound, fueled by renewed investor interest ahead of potential ETF launch.Traders are betting on BONK's growth with a proposed 2x Long BONK ETF, potentially launching by July 16.BONK’s price surge, supported by rising spot net inflows and positive funding rates, signals growing bullish sentiment.Still, BONK’s gains are mostly driven by renewed investor interest ahead of the possible launch of a leveraged exchange-traded fund  tied to the asset.Traders Bet Big on BONK as Potential ETF Launch Nears. Tuttle Capital recently submitted a post-effective amendment to the US Securities and Exchange Commission  for its proposed suite of leveraged ETFs, including a 2x Long BONK ETF.The filing indicates the product could go live as early as July 16.This has reignited enthusiasm around BONK, with traders piling in on speculation that the ETF could attract further inflows and institutional attention. The interest is evident in the token’s rising spot net inflow. A","market":"fut","thumbnail":"https://beincrypto.com/wp-content/uploads/2025/03/ghibli-meme-coin-850x478.png","type":0,"news_type":0,"thumbnails":["https://beincrypto.com/wp-content/uploads/2025/03/ghibli-meme-coin-850x478.png"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://beincrypto.com/bonk-price-rise-amid-etf-excitement/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"beincrypto_highlight","symbols":["FDN","EMA","BK4588","BK4585","BK4081","BK4550"],"gpt_icon":0},{"id":"2548877230","title":"Merck KGaA, Darmstadt, Germany Completes Acquisition of SpringWorks Therapeutics to Accelerate Sustainable Growth of its Healthcare Business","url":"https://stock-news.laohu8.com/highlight/detail?id=2548877230","media":"Business Wire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548877230?lang=en_us&edition=fundamental","pubTime":"2025-07-01 20:30","pubTimestamp":1751373000,"startTime":"0","endTime":"0","summary":"SpringWorks immediately adds revenue and accelerates mid- to long-term growth for Merck KGaA, Darmstadt, Germany’s Healthcare business sector. Acquisition marks the formation of a rare tumor business for Merck KGaA, Darmstadt, Germany including SpringWorks portfolio and pimicotinib. DARMSTADT, Germany, July 01, 2025----Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that it has closed the acquisition of SpringWorks Therapeutics, Inc., for an enterprise value of $3.4 billion *, following regulatory clearances and the fulfillment of other customary closing conditions.The definitive agreement between Merck KGaA, Darmstadt, Germany and SpringWorks, based in Stamford, Connecticut, was announced on 28 April, 2025. It represents one of the biggest M&A deals in the global biopharma sector so far in 2025. The business combination will immediately contribute to Merck KGaA, Darmstadt, Germany’s revenues and is expected to be accretive to the company’s ear","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/merck-kgaa-darmstadt-germany-completes-123000978.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PN","MKGAF","BK4096","CHMP","BK4539","EMA","AAQC","LENZ","BK4137","HCSG","BK4007","BK4139","BK4087","BK4081"],"gpt_icon":0},{"id":"2548003573","title":"Press Release: Apellis to Receive up to $300 Million from Royalty Purchase Agreement with Sobi for Ex-U.S. Royalties of Aspaveli(R) (systemic pegcetacoplan)","url":"https://stock-news.laohu8.com/highlight/detail?id=2548003573","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548003573?lang=en_us&edition=fundamental","pubTime":"2025-07-01 19:01","pubTimestamp":1751367660,"startTime":"0","endTime":"0","summary":"-- Apellis to receive $275 million upfront and up to $25 million in. milestone payments upon EMA approval in C3G and IC-MPGN. -- Non-dilutive financing further strengthens Apellis' balance sheet. -- Apellis retains full U.S. commercialization rights for systemic. \"We are pleased to reaffirm our ongoing partnership with Apellis and share their strong belief in Aspaveli/EMPAVELI's potential to deliver significant long-term growth,\" said Guido Oelkers, chief executive officer, Sobi. \"We are confident in our ability to reach patients with C3G and IC-MPGN globally following regulatory approvals, by leveraging our broad commercial footprint, deep rare disease expertise, and proven success in PNH.\". Under the terms of the agreement, Sobi will acquire 90% of Apellis' ex-U.S. royalties for Aspaveli for $275 million in cash. Apellis wil","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APLS","BK4585","CHMP","BK4022","BK4588","BK4232","R","BK4081","LU1093756168.USD","BK4087","EMA","LU1093756325.SGD","BK4505","BK4139"],"gpt_icon":0},{"id":"2548510048","title":"Legend Biotech’s CAR T Cell Therapies See FDA REMS Removal and EMA Label Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2548510048","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548510048?lang=en_us&edition=fundamental","pubTime":"2025-07-01 04:29","pubTimestamp":1751315388,"startTime":"0","endTime":"0","summary":"Legend Biotech ( ($LEGN) ) has issued an announcement. On June 26, 2025, the FDA removed the Risk Evaluation and Mitigation Strategies (REMS) for L...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/legend-biotechs-car-t-cell-therapies-see-fda-rems-removal-and-ema-label-update?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/legend-biotechs-car-t-cell-therapies-see-fda-rems-removal-and-ema-label-update?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EMA","BK4588","LEGN","BK4230","BK4022","BK4505","BK4081","CAR","BK4139","BK4585"],"gpt_icon":0},{"id":"2547063764","title":"Bitget Onchain Trading Feature Upgrade, Comprehensive Optimization of Take Profit and Stop Loss Module","url":"https://stock-news.laohu8.com/highlight/detail?id=2547063764","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547063764?lang=en_us&edition=fundamental","pubTime":"2025-06-30 16:21","pubTimestamp":1751271660,"startTime":"0","endTime":"0","summary":"BlockBeats News, June 30th, Bitget has made multiple optimizations to its Onchain product to enhance user trading experience. Please update the Bitget App to the latest version to experience these upgrades. The main highlights of this upgrade include:Take Profit and Stop Loss Function Upgrade: One-click preset Take Profit/Stop Loss to help control the trading pace.Trading Indicator Function Update: Added multiple professional data such as EMA, RSI, etc., for accurate market analysis.Current Open Orders Function Optimization: Support viewing details such as slippage, amount, etc., to fully understand trading information.Newbie Exclusive Tutorial Online: Easily view operation tutorials to facilitate quick start of trading.PIN Code Functionality Newly Launched: Multi-layer protection when placing orders to safeguard fund security.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/300544","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["BK4081","RSI","BK4150","EMA"],"gpt_icon":0},{"id":"2547952280","title":"Lower household electricity and gas tariffs from July to September","url":"https://stock-news.laohu8.com/highlight/detail?id=2547952280","media":"CNA","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547952280?lang=en_us&edition=fundamental","pubTime":"2025-06-30 13:16","pubTimestamp":1751260560,"startTime":"0","endTime":"0","summary":"SINGAPORE: Household electricity and gas tariffs will decrease for the period between July and September due to lower energy costs after they remained steady in the previous quarter.Compared with the previous quarter, the electricity tariff will decrease by 2.3 per cent or 0.65 cent per kWh before Goods and Services Tax ,national grid operator SP Group said on Monday .With the electricity tariff before GST at 27.47 cents per kWh, this translates to a fall in the average monthly electricity bill for families living in Housing and Development Board  four-room flats by S$2.36 before GST.The gas tariff before GST will also decrease by 0.44 cent per kWh, from 22.72 cents per kWh to 22.28 cents per kWh for the upcoming quarter due to lower fuel cost, said City Energy.\"The energy cost component of the electricity tariffs for each quarter is set using the average natural gas prices in the first two and a half months in the preceding quarter,\" said SP Group.City Energy also reviews the gas tari","market":"sg","thumbnail":"https://dam.mediacorp.sg/image/upload/s--B3m6D22A--/c_fill,g_auto,h_468,w_830/f_auto,q_auto/v1/mediacorp/cna/image/2023/05/10/istock-1167010779.jpg?itok=H9nwaZQd","type":0,"news_type":0,"thumbnails":["https://dam.mediacorp.sg/image/upload/s--B3m6D22A--/c_fill,g_auto,h_468,w_830/f_auto,q_auto/v1/mediacorp/cna/image/2023/05/10/istock-1167010779.jpg?itok=H9nwaZQd"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.channelnewsasia.com/singapore/electricity-gas-tariffs-decrease-july-september-sp-group-city-energy-5211011","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"can_highlight","symbols":["LU0918141705.HKD","IE00B0JY6M65.USD","LU0197773673.USD","LU0348814723.USD","LU2177674079.SGD","LU2663582299.SGD","BK4588","BK4207","LU0287143357.SGD","LU0231203729.USD","LU0630378429.USD","BK4566","LU0541501648.USD","LU0536402901.SGD","LU1804176565.USD","LU0348744763.USD","LU0918141887.USD","SG9999014013.SGD","HDB","LU1267930656.SGD","LU1508157978.USD","LU1105468828.SGD","LU0797268264.HKD","LU0197773160.USD","LU1791710582.SGD","LU0431992006.USD","LU0541502299.USD","LU2226246903.HKD","LU0348816934.USD","SG9999014021.USD","SG9999014039.USD","LU0528227936.USD","BK4523","BK4081","LU2008162690.USD","LU0390134368.USD","BK4535","LU0630378692.HKD","SG9999014005.SGD","LU2265009873.SGD","LU2279701549.SGD","GST","IE00B7N09G41.SGD","LU0456842615.SGD","LU1854104046.USD","LU0868486357.SGD","EMA","LU0197229882.USD","LU1805238398.USD","IE00BYTNYM70.SGD"],"gpt_icon":0},{"id":"2547818460","title":"SEI Price Is Close to Ending a 5-Month Death Cross After 50% Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=2547818460","media":"BE[IN]CRYPTO","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547818460?lang=en_us&edition=fundamental","pubTime":"2025-06-29 19:30","pubTimestamp":1751196600,"startTime":"0","endTime":"0","summary":"SEI has surged 50% this week, reaching a 4-month high and showing growing investor interest, particularly with a surge in daily transactions.The altcoin is approaching the key resistance level of $0.30 and could break through it, potentially marking the end of a 5-month-long Death Cross and triggering a Golden Cross.However, if profit-taking occurs, SEI could dip to $0.27 or even $0.24, which would reverse the current bullish momentum.SEI has seen a sharp surge in price recently, marking a significant uptick likely driven by growing interest in alternative chains.This surge comes after months of consolidation, and the rise in transaction volume could further fuel price gains. However, questions remain if this momentum will end the five-month-long Death Cross.However, the recent price surge has sparked a slight uptick in the 50-day EMA, suggesting that a change in trend could be on the horizon.However, if investors choose to book profits, SEI could face a correction. A drop through the ","market":"nz","thumbnail":"https://beincrypto.com/wp-content/uploads/2023/05/bic_SEI_network_post_coin_funnel-850x478.jpg.optimal.jpg","type":0,"news_type":0,"thumbnails":["https://beincrypto.com/wp-content/uploads/2023/05/bic_SEI_network_post_coin_funnel-850x478.jpg.optimal.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://beincrypto.com/sei-price-rally-close-to-golden-cross/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"beincrypto_highlight","symbols":["IE0031619046.USD","BK4081","IE00B66KJ199.SGD","SEI","IE00B7SZL793.SGD","IE00B19Z4B17.USD","EMA","BK4179"],"gpt_icon":0},{"id":"2546710470","title":"Aptos Hits 16-Day High as First-Ever Aptos Spot ETF Inches Closer to Reality","url":"https://stock-news.laohu8.com/highlight/detail?id=2546710470","media":"BE[IN]CRYPTO","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546710470?lang=en_us&edition=fundamental","pubTime":"2025-06-27 18:30","pubTimestamp":1751020200,"startTime":"0","endTime":"0","summary":"Aptos  surges nearly 10%, reaching a 16-day high amid growing optimism over Bitwise’s updated ETF filing.Bitwise’s updated S-1 filing for a spot Aptos ETF signals potential institutional inflows, boosting APT demand.APT remains above its 20-day EMA, indicating bullish momentum with key support at $4.68, potentially pushing towards $5.99.Layer-1  proof-of-stake coin APT is today’s top-performing crypto asset, rising nearly 10% over the past 24 hours.The bullish momentum comes after Bitwise filed an updated S-1 form with the US SEC on Thursday for its proposed spot Aptos exchange-traded fund . This marks a significant step forward in bringing the first-ever Aptos ETF to the US market.The 20-day EMA measures an asset’s average price over the past 20 trading days, giving weight to recent prices. When an asset’s price trades above the 20-day EMA, it signals short-term bullish momentum and suggests buyers are in control.However, if demand stalls, APT’s price could break below its 20-day EMA ","market":"us","thumbnail":"https://beincrypto.com/wp-content/uploads/2024/04/bic_Aptos_APT_4-covers_bullish-850x478.jpg.optimal.jpg","type":0,"news_type":0,"thumbnails":["https://beincrypto.com/wp-content/uploads/2024/04/bic_Aptos_APT_4-covers_bullish-850x478.jpg.optimal.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://beincrypto.com/aptos-apt-price-reaches-high-etf-pause/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"beincrypto_highlight","symbols":["BK4585","APT","BK4568","APT.USD.HKCC","BK4588","BK4086","APT.USD.CC","EMA","BK4550","FDN","BK4081"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":69,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EMA\",params:#limit:5,,,undefined,":[{"date":"2025-08-08","symbol":"EMA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/06","expectedEps":null,"defaultRemindTime":1754640000000,"name":null,"time":"Pre-Market","dateTimestamp":1754625600000,"actualEps":null},{"date":"2025-08-01","symbol":"EMA","amount":0.725,"announcedDate":"2025-07-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-08-01","defaultRemindTime":1754055000000,"name":"Emera Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-15","payableDate":"2025-08-01","currency":"CAD","dateTimestamp":1754020800000,"payDate":"2025-08-15"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EMA\",market:\"US\",,,undefined,":[{"executeDate":"2015-07-29","recordDate":"2015-07-31","paymentDate":"2015-08-17","value":0.305564,"currency":"USD"},{"executeDate":"2015-10-29","recordDate":"2015-11-02","paymentDate":"2015-11-16","value":0.3565682,"currency":"USD"},{"executeDate":"2016-01-29","recordDate":"2016-02-02","paymentDate":"2016-02-16","value":0.3421147,"currency":"USD"},{"executeDate":"2016-04-28","recordDate":"2016-05-02","paymentDate":"2016-05-16","value":0.3682105,"currency":"USD"},{"executeDate":"2016-07-20","recordDate":"2016-07-22","paymentDate":"2016-08-15","value":0.4045038,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EMA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.0667,"buy":0.4,"hold":0.4667,"sell":0,"strongSell":0.0667,"meanLabel":"HOLD","meanPercent":0.4667,"analysts":15,"updateTime":1751169600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EMA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EMA","date":"2025-07-18","current":19.592532,"percent":0.545455,"low":19.106036,"twenty":19.308216,"median":19.502499,"eighty":19.712577,"high":19.892644,"avg":19.509467,"sd":0.223852,"marketCap":13439260670.95},"quantilePoints":[{"date":"2025-05-30","current":19.76944,"twenty":19.76944,"median":19.76944,"eighty":19.76944,"marketCap":13505496352.43},{"date":"2025-06-06","current":19.324012,"twenty":19.535669,"median":19.692043,"eighty":19.76944,"marketCap":13350532994.37},{"date":"2025-06-13","current":19.308216,"twenty":19.137627,"median":19.324012,"eighty":19.722054,"marketCap":13371262392.6},{"date":"2025-06-20","current":19.245035,"twenty":19.160372,"median":19.387193,"eighty":19.674036,"marketCap":13211518175.96},{"date":"2025-06-27","current":19.308216,"twenty":19.224185,"median":19.382455,"eighty":19.560942,"marketCap":13348226238.04},{"date":"2025-07-03","current":19.469329,"twenty":19.242508,"median":19.399829,"eighty":19.679723,"marketCap":13533023992.92},{"date":"2025-07-11","current":19.753645,"twenty":19.282944,"median":19.43142,"eighty":19.706259,"marketCap":13611556279.78},{"date":"2025-07-18","current":19.592532,"twenty":19.308216,"median":19.502499,"eighty":19.712577,"marketCap":13439260670.95}],"updateTime":1753134681167}}}